Naprosyn Ec (Naproxen)

Naproxen, the active ingredient in Naprosyn Ec, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It reduces pain, inflammation and fever, and is commonly prescribed for conditions such as arthritis, musculoskeletal pain and dysmenorrhea in adults.

GNH USA supplies Naprosyn Ec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and reliable logistics. The company adheres to stringent regulatory standards and provides comprehensive support for product registration and distribution across multiple regions.

Naproxen, marketed as Naprosyn Ec, is an NSAID that alleviates pain and inflammation across several musculoskeletal and gynecologic conditions.

- Pain: Provides relief from mild to moderate acute pain such as dental, postoperative or musculoskeletal discomfort. - Inflammation: Reduces swelling and inflammatory response in conditions like osteoarthritis and rheumatoid arthritis. - Arthritis: Improves joint function and decreases stiffness associated with osteoarthritis and rheumatoid arthritis. - Dysmenorrhea: Alleviates menstrual cramps and associated pelvic pain in primary dysmenorrhea.

Naproxen may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort such as nausea, dyspepsia, abdominal pain or heartburn. - Headache or mild dizziness, occasionally accompanied by visual disturbances. - Skin rash, pruritus or mild erythema, typically transient.

Serious or Rare Side Effects: - Gastrointestinal bleeding, ulceration or perforation, which may present with melena or hematemesis. - Cardiovascular events including myocardial infarction, stroke or worsening of hypertension. - Severe cutaneous reactions such as Stevens‑Johnson syndrome, toxic epidermal necrolysis or drug‑induced rash with systemic symptoms.

When prescribing naproxen, clinicians should consider several precautionary measures to minimize risks.

- Assess gastrointestinal risk: evaluate history of ulcers, bleeding or concurrent NSAID use. - Evaluate cardiovascular status: consider existing heart disease, hypertension or stroke risk. - Monitor renal function: check baseline kidney parameters, especially in elderly or dehydrated patients. - Use lowest effective dose: limit duration to the shortest period necessary for symptom control. - Avoid in known hypersensitivity: discontinue if allergic reactions such as rash or bronchospasm occur. - Store at room temperature: keep tablets in the original container, protect from moisture and heat.

Naproxen can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding risk.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal clearance of naproxen. - ACE inhibitors or ARBs: potential for reduced antihypertensive effect and renal impairment. - Alcohol: can exacerbate gastrointestinal irritation and bleeding.